CACI
CACI International Inc
CACI's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CACI overall, supported by stronger valuation and stronger modeled upside.
CACI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Under pressure |
CACI's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CACI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $397 | -38% |
| Forward | 19x | $644 | — |
| Fair | 20x | $483 | -25% |
| Expensive | 25x | $606 | -5.9% |
| Current | 26x | $644 | — |
Historical ranges are pointers, not guarantees.
CACI's PE is in its expensive range at 26x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its fair range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CACI in the historical PE scenario, which offers more potential upside but is not a forecast.
CACI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
CACI has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CACI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $34.68 | +42% |
| Q3 2026 | $24.37 | +7.7% |
| Q2 2026 | $24.16 | +8.2% |
| Q1 2026 | $24.21 | +14% |
| Q4 2025 | $23.33 | +9.5% |
| Q3 2025 | $22.62 | +12% |
| Q2 2025 | $22.32 | +20% |
| Q1 2025 | $21.18 | +22% |
| Q4 2024 | $21.31 | +29% |
CACI's earnings per share have climbed steadily: $24.37 over the past year, up 7.7% from the year before, and higher year over year for 14 quarters in a row.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CACI on earnings, with stronger typical year-over-year growth.
CACI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.5B | +8.2% |
| Q2 2026 | $2.7B | +18% |
| Q1 2026 | $2.4B | +8.5% |
| Q4 2025 | $2.2B | +5.7% |
| Q3 2025 | $2.3B | +11% |
| Q2 2025 | $2.3B | +13% |
| Q1 2025 | $2.2B | +12% |
| Q4 2024 | $2.1B | +14% |
CACI's revenue has grown year over year every quarter since late 2020: $2.5B last quarter, up 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +0.7 points |
| Q2 2026 | 10% | +1.1 points |
| Q1 2026 | 9.7% | +0.7 points |
| Q4 2025 | 9.3% | +0.7 points |
| Q3 2025 | 9.3% | +0.5 points |
| Q2 2025 | 9% | -0.7 points |
| Q1 2025 | 9.1% | -0.3 points |
| Q4 2024 | 8.6% | +1.4 points |
CACI's operating margin was 10% last quarter, up 0.7 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CACI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CACI on profitability, with a higher operating margin.
CACI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $150M | -2.7% |
| Q2 2026 | $331.5M | +159% |
| Q1 2026 | $156.4M | -27% |
| Q4 2025 | $138.2M | +19% |
| Q3 2025 | $154.1M | +564% |
| Q2 2025 | $128M | -4.9% |
| Q1 2025 | $214.1M | +15% |
| Q4 2024 | $116.1M | +106% |
CACI's free cash flow has been positive every quarter for seven years: $776M over the past year, up 27% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CACI on cash flow, with more consistent year-over-year improvement.
CACI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +140K shares |
| 1 year | +0.7% | +150K shares |
| 3 years | -2.5% | -578K shares |
| 5 years | -6.4% | -1.5M shares |
| Available history | -12% | -3.1M shares |
CACI has 22M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4M |
| Q2 2026 | $4.4M |
| Q1 2026 | $3.7M |
| Q4 2025 | $4.9M |
| Q3 2025 | $4.1M |
| Q2 2025 | $4.6M |
| Q1 2025 | $153.6M |
| Q4 2024 | $7.1M |
CACI spent $17M buying back its own shares over the past year, down 90% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CACI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CACI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.7x | Elevated |
| Q2 2026 | 4.0x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 2.4x | Moderate |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.2x | Elevated |
CACI's net debt is about 3.7 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over CACI on leverage, with a lower net debt burden relative to earnings.
CACI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.9 | Neutral |
| Stochastic | 69.7 | Neutral |
CACI's weekly RSI is 58 (neutral) and its Stochastic is 70 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CACI PE vs Technology Sector
| Metric | CACI | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 28x | 5.2% below |
| PE % | 94 | 35 | 59 pts above |
CACI is trading at 26x earnings, in line with the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CACI on valuation relative to its sector.
CACI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $627.9 | 2.5% above |
| 20 week MA | $596.0 | 8% above |
| 50 week MA | $572.9 | 12% above |
| 100 week MA | $516.1 | 25% above |
| 200 week MA | $444.8 | 45% above |
CACI has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CACI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $250.8 | $246.5 | -1.7% |
| 2021 | $246.5 | $266.7 | +8.2% |
| 2022 | $266.7 | $299.3 | +12% |
| 2023 | $299.3 | $323.9 | +8.2% |
| 2024 | $323.9 | $406.2 | +25% |
| 2025 | $406.2 | $542.0 | +33% |
| 2026 YTD | $542.0 | $643.9 | +19% |
CACI has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.